[Clinical and physiopathological effects of Vincristine on the nervous system].
D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D001369:Axons / Q000187:drug effects; D004576:Electromyography; D005158:Facial Paralysis / Q000139:chemically induced; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009046:Motor Neurons / Q000187:drug effects; D009133:Muscular Atrophy / Q000139:chemically induced; D009422:Nervous System Diseases / Q000139:chemically induced*; D009460:Neurologic Examination; D009475:Neurons, Afferent / Q000187:drug effects; D010291:Paresis / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D012018:Reflex / Q000187:drug effects; D014110:Touch / Q000187:drug effects; D014750:Vincristine / Q000009:adverse effects*
D014750:Vincristine
Zur Klinik und Pathophysiologie der Vincristinwirkungen am Nervensystem.